AFC PREVALENCE TABLE 2
State/Territory | Sample size± |
Active | Inactive | ||||||
---|---|---|---|---|---|---|---|---|---|
Sample size |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | ||
Connecticut | 218 | 170 | 76.2 | 3.9 | (67.6 – 83.1) | 48 | 23.8 | 3.9 | (16.9 – 32.4) |
Hawaii | 184 | 125 | 74.9 | 5.8 | (62.0 – 84.5) | 59 | 25.1 | 5.8 | (15.5 – 38.0) |
Kansas | 288 | 233 | 83.3 | 2.7 | (77.2 – 88.0) | 55 | 16.7 | 2.7 | (12.0 – 22.8) |
Louisiana | 101 | 78 | 76.6 | 5.3 | (64.7 – 85.4) | 23 | 23.4 | 5.3 | (14.6 – 35.3) |
Maine | 139 | 95 | 67.4 | 4.9 | (57.2 – 76.1) | 44 | 32.6 | 4.9 | (23.9 – 42.8) |
Maryland | 268 | 207 | 80.1 | 3.4 | (72.6 – 86.0) | 61 | 19.9 | 3.4 | (14.0 – 27.4) |
Massachusetts | 86 | 66 | 82.1 | 5.9 | (67.7 – 91.0) | 20 | N/A | N/A | (N/A – N/A) |
Michigan | 378 | 296 | 79.0 | 2.6 | (73.5 – 83.6) | 82 | 21.0 | 2.6 | (16.4 – 26.5) |
Mississippi | 210 | 165 | 84.0 | 3.1 | (76.9 – 89.2) | 45 | 16.0 | 3.1 | (10.8 – 23.1) |
Missouri | 141 | 112 | 80.6 | 4.3 | (70.8 – 87.7) | 29 | 19.4 | 4.3 | (12.3 – 29.2) |
Montana | 188 | 147 | 73.4 | 5.2 | (61.9 – 82.4) | 41 | 26.6 | 5.2 | (17.6 – 38.1) |
Nebraska | 392 | 291 | 75.3 | 3.1 | (68.6 – 80.9) | 101 | 24.7 | 3.1 | (19.1 – 31.4) |
New Hampshire | 152 | 113 | 77.4 | 4.6 | (67.2 – 85.1) | 39 | 22.6 | 4.6 | (14.9 – 32.8) |
New Jersey | 375 | 295 | 84.4 | 2.0 | (80.0 – 88.0) | 80 | 15.6 | 2.0 | (12.0 – 20.0) |
New Mexico | 198 | 146 | 70.7 | 4.1 | (62.1 – 78.0) | 52 | 29.3 | 4.1 | (22.0 – 37.9) |
New York | 116 | 80 | 74.3 | 5.1 | (63.1 – 83.0) | 36 | 25.7 | 5.1 | (17.0 – 36.9) |
Ohio | 208 | 166 | 80.7 | 3.2 | (73.7 – 86.1) | 42 | 19.3 | 3.2 | (13.9 – 26.3) |
Oklahoma | 167 | 127 | 80.9 | 3.6 | (72.9 – 87.0) | 40 | 19.1 | 3.6 | (13.0 – 27.1) |
Oregon | 93 | 66 | 71.4 | 5.7 | (59.0 – 81.2) | 27 | 28.6 | 5.7 | (18.8 – 41.0) |
Pennsylvania | 336 | 258 | 79.0 | 2.9 | (72.8 – 84.1) | 78 | 21.0 | 2.9 | (15.9 – 27.2) |
Rhode Island | 115 | 85 | 82.4 | 4.4 | (72.2 – 89.4) | 30 | 17.6 | 4.4 | (10.6 – 27.8) |
Texas | 301 | 220 | 78.5 | 3.2 | (71.6 – 84.1) | 81 | 21.5 | 3.2 | (15.9 – 28.4) |
Utah | 446 | 333 | 73.8 | 2.9 | (67.8 – 79.1) | 113 | 26.2 | 2.9 | (20.9 – 32.2) |
Washington | 234 | 159 | 70.5 | 3.7 | (62.7 – 77.3) | 75 | 29.5 | 3.7 | (22.7 – 37.3) |
West Virginia | 145 | 119 | 82.2 | 4.0 | (73.0 – 88.7) | 26 | 17.8 | 4.0 | (11.3 – 27.0) |
Wisconsin | 134 | 103 | 73.1 | 6.6 | (58.5 – 84.0) | 31 | 26.9 | 6.6 | (16.0 – 41.5) |
26 state total | 5,613 | 4,255 | 78.1 | 1.1 | (76.0 – 80.1) | 1,358 | 21.9 | 1.1 | (19.9 – 24.0) |
Median | 78.0 | 22.6 | |||||||
Range | 67.4-84.4 | 15.6-32.6 |
1 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
2 Reported none of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
3 Aged < 18 years
± Sample size is for multiple years of participation. Responses of “Don’t Know” and “Refused” are excluded.
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the relative standard error was > 0.30
Page last reviewed: September 10, 2018